Navis Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Navis Wealth Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$385K	Sell	2,431 -32	-1%	-$4.33K	0.15%	114
2026 Q1	$315K	Buy	2,463 +663	+37%	+$82.8K	0.16%	129
2025 Q4	$219K	Sell	1,800 -600	-25%	-$68.8K	0.09%	165
2025 Q3	$240K	Buy	+2,400	New	+$216K	0.18%	108
2025 Q1	–	Sell	-4,500	Closed	-$405K	–	110
2024 Q4	$405K	Buy	4,500 +2,100	+88%	+$203K	0.44%	53
2024 Q3	$237K	Sell	2,400 -280	-10%	-$27.5K	0.26%	89
2024 Q2	$248K	Hold	2,680	–	–	0.29%	84
2024 Q1	$254K	Buy	+2,680	New	+$249K	0.31%	80
2022 Q4	–	Sell	-6,612	Closed	-$524K	–	95
2022 Q3	$524K	Hold	6,612	–	–	0.81%	29
2022 Q2	$491K	Sell	6,612 -1,550	-19%	-$116K	0.53%	41
2022 Q1	$734K	Buy	8,162 +100	+1%	+$9.23K	0.65%	38
2021 Q4	$903K	Buy	8,062 +1,450	+22%	+$175K	0.76%	30
2021 Q3	$831K	Hold	6,612	–	–	0.58%	40
2021 Q2	$895K	Hold	6,612	–	–	0.75%	29
2021 Q1	$897K	Buy	6,612 +2	+0%	+$299	0.69%	32
2020 Q4	$931K	Buy	+6,610	New	+$847K	0.84%	27

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Navis Wealth Advisors's XBI Position: Q2 2026 in Review

Navis Wealth Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.3% in Q2 2026, selling an estimated $4.33K and leaving 2,431 shares worth $385K. The position accounts for 0.15% of the portfolio, ranked #114.

Navis Wealth Advisors first reported a position in XBI in Q4 2020 and has held it in 16 quarters since. The position peaked at $931K in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Navis Wealth Advisors held 2,431 shares of State Street SPDR S&P Biotech ETF worth $385K as of Q2 2026.
Navis Wealth Advisors sold 32 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.33K.
State Street SPDR S&P Biotech ETF made up 0.15% of Navis Wealth Advisors's portfolio in Q2 2026, its #114 holding.
Navis Wealth Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 16 quarters since.
Navis Wealth Advisors's State Street SPDR S&P Biotech ETF position peaked at $931K in Q4 2020.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Navis Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.